fainting on glp 1 Trump Freezes as GLP-1 Patient Collapses Right Behind Him in Oval Office Can Weight Loss Injections Cause

The NAPA Quality team then collaborated with the ABG QCDR, administered by Graphium Health, to submit this measure to CMS for inclusion in the 2025 Quality Payment Program (QPP) MIPS track as ABG 45: Aspiration Prevention in Patients with Gastric Distension. Rafael Cartagena , MD, NAPA CEO, emphasized NAPA leadership in advancing anesthesia safety

Bertilsson et al

Keep a Log: Track your sites in a notebook or phone app to avoid repeats

These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist, not a pure GLP-1 agonist

G.CohenE

Endocrine 2020